PT Millennium Pharmacon International Tbk (IDX:SDPC)
191.00
+3.00 (1.60%)
Feb 10, 2026, 2:55 PM WIB
IDX:SDPC Revenue
PT Millennium Pharmacon International Tbk had revenue of 1.06T IDR in the quarter ending September 30, 2025, with 7.69% growth. This brings the company's revenue in the last twelve months to 3.99T, up 3.82% year-over-year. In the year 2024, PT Millennium Pharmacon International Tbk had annual revenue of 3.92T with 16.45% growth.
Revenue (ttm)
3.99T
Revenue Growth
+3.82%
P/S Ratio
0.06
Revenue / Employee
3.39B
Employees
1,180
Market Cap
239.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.92T | 553.35B | 16.45% |
| Dec 31, 2023 | 3.36T | 162.68B | 5.08% |
| Dec 31, 2022 | 3.20T | 211.98B | 7.09% |
| Dec 31, 2021 | 2.99T | 345.22B | 13.06% |
| Dec 31, 2020 | 2.64T | -83.13B | -3.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 34.38T |
| PT Siloam International Hospitals Tbk | 12.51T |
| PT Soho Global Health Tbk | 10.51T |
| PT Sejahteraraya Anugrahjaya Tbk | 3.30T |
| PT Phapros Tbk | 856.09B |
| PT Royal Prima Tbk | 332.14B |
| PT Indofarma Tbk | 206.24B |
| PT Diagnos Laboratorium Utama Tbk | 157.99B |